Sara Mangsbo

Sara Mangsbo is a Professor at Uppsala University, specializing in antibody-based drugs and immunotherapies in oncology since April 2016. Mangsbo has held various academic and leadership roles, including Senior Lecturer and Associate Senior Lecturer in Pharmaceutical Biosciences, Chief Scientific Officer and Co-Founder at Strike Pharma AB, and Chief Development Officer at Ultimovacs. Mangsbo has also served as a founder and board member at Immuneed and was the Nordic Brand Lead for Immuno-oncology at AstraZeneca. Mangsbo's research focuses on developing novel immunotherapies and combination strategies for cancer treatment, earning a PhD in Clinical Immunology and Cancer Therapy from Uppsala University. Mangsbo's consulting work and postdoctoral research have significantly contributed to advancements in immunology and cancer therapy.